Genetic Characterization and Virulence Role of the RALP3/LSA Locus Upstream of the Streptolysin S Operon in Invasive M1T1 Group A Streptococcus

Overview

Journal J Bacteriol

Publisher American Society for Microbiology

Specialty Microbiology

Date 2006 Nov 23

PMID 17114267

Citations 21

Authors

Laura A Kwinn

Arya Khosravi

Ramy K Aziz

Anjuli M Timmer

Kelly S Doran

Malak Kotb

Victor Nizet

Affiliations

Soon will be listed here.

Abstract

Group A Streptococcus (GAS) is a leading human pathogen associated with a wide spectrum of mucosal and invasive infections. GAS expresses a large number of virulence determinants whose expression is under the control of several transcriptional regulatory networks. Here we performed the first mutational analysis of a genetic locus immediately upstream of the streptolysin S biosynthetic operon in several GAS genome sequences, including that of the M1T1 serotype, the leading isolates associated with serious invasive disease. The locus consists of a predicted RofA-like stand-alone transcriptional regulator (RALP3) and the largest open reading frame in the GAS genome, encoding a predicted LPXSG motif cell wall-anchored protein we have named LSA (for "large surface-anchored" protein). Comparative reverse transcription-PCR analysis of wild-type M1T1 GAS and an isogenic RALP3-deficient mutant identifies RALP3 as a global transcriptional regulator affecting expression of numerous virulence factor genes, including those for strong repression of the hyaluronic acid capsule and cysteine protease production. RALP3 contributed to GAS epithelial cell invasion and bloodstream survival. LSA was found to be under negative regulation by RALP3 and to influence GAS-epithelial cell interactions and GAS antimicrobial peptide sensitivity. Isogenic M1T1 GAS mutants lacking either RALP3 or LSA were attenuated in a murine model of systemic infection, indicating that this locus plays a role in the virulence potential of the organism.

Citing Articles

Emergent group A evidences a survival strategy during interaction with immune effector cells.

Odo C, Vega L, Mukherjee P, DebRoy S, Flores A, Shelburne S Infect Immun. 2024; 92(7):e0015224.

PMID: 38888310 PMC: 11238559. DOI: 10.1128/iai.00152-24.

PRD-Containing Virulence Regulators (PCVRs) in Pathogenic Bacteria.

Rom J, Hart M, McIver K Front Cell Infect Microbiol. 2021; 11:772874.

PMID: 34737980 PMC: 8560693. DOI: 10.3389/fcimb.2021.772874.

("Group A Streptococcus"), a Highly Adapted Human Pathogen-Potential Implications of Its Virulence Regulation for Epidemiology and Disease Management.

Siemens N, Lutticken R Pathogens. 2021; 10(6).

PMID: 34205500 PMC: 8234341. DOI: 10.3390/pathogens10060776.

Genetics, Structure, and Function of Group A Streptococcal Pili.

Nakata M, Kreikemeyer B Front Microbiol. 2021; 12:616508.

PMID: 33633705 PMC: 7900414. DOI: 10.3389/fmicb.2021.616508.

In silico characterisation of stand-alone response regulators of Streptococcus pyogenes.

Buckley S, Davies M, McMillan D PLoS One. 2020; 15(10):e0240834.

PMID: 33075055 PMC: 7571705. DOI: 10.1371/journal.pone.0240834.

References

Clarke S, Harris L, Geoff Richards R, Foster S . Analysis of Ebh, a 1.1-megadalton cell wall-associated fibronectin-binding protein of Staphylococcus aureus. Infect Immun. 2002; 70(12):6680-7. PMC: 133066. DOI: 10.1128/IAI.70.12.6680-6687.2002. View

Granok A, Parsonage D, Ross R, Caparon M . The RofA binding site in Streptococcus pyogenes is utilized in multiple transcriptional pathways. J Bacteriol. 2000; 182(6):1529-40. PMC: 94449. DOI: 10.1128/JB.182.6.1529-1540.2000. View

Mitchell T . The pathogenesis of streptococcal infections: from tooth decay to meningitis. Nat Rev Microbiol. 2004; 1(3):219-30. DOI: 10.1038/nrmicro771. View

Kreikemeyer B, McIver K, Podbielski A . Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen-host interactions. Trends Microbiol. 2003; 11(5):224-32. DOI: 10.1016/s0966-842x(03)00098-2. View

Nizet V, Beall B, Bast D, Datta V, Kilburn L, Low D . Genetic locus for streptolysin S production by group A streptococcus. Infect Immun. 2000; 68(7):4245-54. PMC: 101736. DOI: 10.1128/IAI.68.7.4245-4254.2000. View

Engleberg N, Heath A, Vardaman K, DiRita V . Contribution of CsrR-regulated virulence factors to the progress and outcome of murine skin infections by Streptococcus pyogenes. Infect Immun. 2004; 72(2):623-8. PMC: 321567. DOI: 10.1128/IAI.72.2.623-628.2004. View

Ferretti J, McShan W, Ajdic D, Savic D, Savic G, Lyon K . Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc Natl Acad Sci U S A. 2001; 98(8):4658-63. PMC: 31890. DOI: 10.1073/pnas.071559398. View

Raeder R, Woischnik M, Podbielski A, Boyle M . A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties. Res Microbiol. 1998; 149(8):539-48. DOI: 10.1016/s0923-2508(99)80001-1. View

Datta V, Myskowski S, Kwinn L, Chiem D, Varki N, Kansal R . Mutational analysis of the group A streptococcal operon encoding streptolysin S and its virulence role in invasive infection. Mol Microbiol. 2005; 56(3):681-95. DOI: 10.1111/j.1365-2958.2005.04583.x. View

10.

Aziz R, Pabst M, Jeng A, Kansal R, Low D, Nizet V . Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB. Mol Microbiol. 2003; 51(1):123-34. DOI: 10.1046/j.1365-2958.2003.03797.x. View

11.

BISNO A, Brito M, Collins C . Molecular basis of group A streptococcal virulence. Lancet Infect Dis. 2003; 3(4):191-200. DOI: 10.1016/s1473-3099(03)00576-0. View

12.

Hakansson A, Cywes Bentley C, Shakhnovic E, Wessels M . Cytolysin-dependent evasion of lysosomal killing. Proc Natl Acad Sci U S A. 2005; 102(14):5192-7. PMC: 555683. DOI: 10.1073/pnas.0408721102. View

13.

Gryllos I, Cywes C, Shearer M, Cary M, Kennedy R, Wessels M . Regulation of capsule gene expression by group A Streptococcus during pharyngeal colonization and invasive infection. Mol Microbiol. 2001; 42(1):61-74. DOI: 10.1046/j.1365-2958.2001.02635.x. View

14.

Federle M, McIver K, Scott J . A response regulator that represses transcription of several virulence operons in the group A streptococcus. J Bacteriol. 1999; 181(12):3649-57. PMC: 93840. DOI: 10.1128/JB.181.12.3649-3657.1999. View

15.

Cockerill 3rd F, MacDonald K, Thompson R, Roberson F, Kohner P, Manahan J . An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA. 1997; 277(1):38-43. View

16.

Cywes C, Wessels M . Group A Streptococcus tissue invasion by CD44-mediated cell signalling. Nature. 2001; 414(6864):648-52. DOI: 10.1038/414648a. View

17.

Heath A, DiRita V, Barg N, Engleberg N . A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B. Infect Immun. 1999; 67(10):5298-305. PMC: 96884. DOI: 10.1128/IAI.67.10.5298-5305.1999. View

18.

Jeng A, Sakota V, Li Z, Datta V, Beall B, Nizet V . Molecular genetic analysis of a group A Streptococcus operon encoding serum opacity factor and a novel fibronectin-binding protein, SfbX. J Bacteriol. 2003; 185(4):1208-17. PMC: 142848. DOI: 10.1128/JB.185.4.1208-1217.2003. View

19.

Beckert S, Kreikemeyer B, Podbielski A . Group A streptococcal rofA gene is involved in the control of several virulence genes and eukaryotic cell attachment and internalization. Infect Immun. 2000; 69(1):534-7. PMC: 97913. DOI: 10.1128/IAI.69.1.534-537.2001. View

20.

Kristian S, Datta V, Weidenmaier C, Kansal R, Fedtke I, Peschel A . D-alanylation of teichoic acids promotes group a streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion. J Bacteriol. 2005; 187(19):6719-25. PMC: 1251589. DOI: 10.1128/JB.187.19.6719-6725.2005. View